{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:51:46Z","timestamp":1792270306557,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00210-012-0740-4","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T06:15:59Z","timestamp":1336457759000},"page":"823-831","source":"Crossref","is-referenced-by-count":43,"title":["Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway"],"prefix":"10.1007","volume":"385","author":[{"given":"Shu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-zhou","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-min","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"740_CR1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/FJC.0b013e318046f34a","volume":"49","author":"W Bao","year":"2007","unstructured":"Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL (2007) Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. J Cardiovasc Pharmacol 49:362\u2013368","journal-title":"J Cardiovasc Pharmacol"},{"key":"740_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191\u2013227","journal-title":"Pharmacol Ther"},{"key":"740_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1196\/annals.1341.008","volume":"1047","author":"DM Bers","year":"2005","unstructured":"Bers DM, Guo T (2005) Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 1047:86\u201398","journal-title":"Ann N Y Acad Sci"},{"key":"740_CR4","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.072647999","volume":"99","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD (2002) Impaired cardiac hypertrophic response in calcineurin Abeta-deficient mice. Proc Natl Acad Sci U S A 99:4586\u20134591","journal-title":"Proc Natl Acad Sci U S A"},{"key":"740_CR5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","volume":"93","author":"JA Byrne","year":"2003","unstructured":"Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93:802\u2013805","journal-title":"Circ Res"},{"key":"740_CR6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.107.155721","volume":"101","author":"E Cingolani","year":"2007","unstructured":"Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marban E (2007) Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res 101:166\u2013175","journal-title":"Circ Res"},{"key":"740_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.109.139519","volume":"55","author":"DL Dong","year":"2010","unstructured":"Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF (2010) Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55:946\u2013952","journal-title":"Hypertension"},{"key":"740_CR8","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","volume":"43","author":"MH Drazner","year":"2004","unstructured":"Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, Siscovick DS (2004) Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the cardiovascular health study. J Am Coll Cardiol 43:2207\u20132215","journal-title":"J Am Coll Cardiol"},{"key":"740_CR9","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/CIRCULATIONAHA.107.711317","volume":"116","author":"D Frank","year":"2007","unstructured":"Frank D, Kuhn C, van Eickels M, Gehring D, Hanselmann C, Lippl S, Will R, Katus HA, Frey N (2007) Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy. Circulation 116:2587\u20132596","journal-title":"Circulation"},{"key":"740_CR10","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580\u20131589","journal-title":"Circulation"},{"key":"740_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"740_CR12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.HYP.0000163462.98381.7f","volume":"45","author":"S Kimura","year":"2005","unstructured":"Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y (2005) Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45:860\u2013866","journal-title":"Hypertension"},{"key":"740_CR13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.biocel.2008.03.002","volume":"40","author":"MV Latronico","year":"2008","unstructured":"Latronico MV, Elia L, Condorelli G, Catalucci D (2008) Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment. Int J Biochem Cell Biol 40:1643\u20131648","journal-title":"Int J Biochem Cell Biol"},{"key":"740_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jcb.22038","volume":"106","author":"KS Lee","year":"2009","unstructured":"Lee KS, Park JH, Lee S, Lim HJ, Park HY (2009) PPARdelta activation inhibits angiotensin II-induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway. J Cell Biochem 106:823\u2013834","journal-title":"J Cell Biochem"},{"key":"740_CR15","first-page":"84","volume":"36","author":"Y Liu","year":"2001","unstructured":"Liu Y, Wang Y, Ma ML, Zhang Y, Li HW, Chen QW, Yang BF (2001) Cardiac-hemodynamic effects of M3 receptor agonist on rat and rabbit hearts. Yao Xue Xue Bao 36:84\u201387","journal-title":"Yao Xue Xue Bao"},{"key":"740_CR16","first-page":"338","volume":"39","author":"Y Liu","year":"2004","unstructured":"Liu Y, Jing YH, Sun HL, Li HL, Yang BF (2004) Relationship between M3 receptor and myocyte apoptosis induced by acute myocardial infarction. Yao Xue Xue Bao 39:338\u2013341","journal-title":"Yao Xue Xue Bao"},{"key":"740_CR17","first-page":"8","volume":"40","author":"Y Liu","year":"2005","unstructured":"Liu Y, Xu CQ, Jiao JD, Wang HZ, Dong DL, Yang BF (2005) M3-R\/IKM3\u2014A new target of antiarrhythmic agents. Yao Xue Xue Bao 40:8\u201312","journal-title":"Yao Xue Xue Bao"},{"key":"740_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00210-008-0376-6","volume":"379","author":"Y Liu","year":"2009","unstructured":"Liu Y, Du J, Gao Y, Zhang Y, Cai BZ, Zhao H, Qi HP, Du ZM, Lu YJ, Yang BF (2009) Role of M3 receptor in aconitine\/barium-chloride-induced preconditioning against arrhythmias in rats. Naunyn-Schmied Arch Pharmacol 379:511\u2013515","journal-title":"Naunyn-Schmied Arch Pharmacol"},{"key":"740_CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10495-010-0549-x","volume":"16","author":"JJ Liu","year":"2011","unstructured":"Liu JJ, Li DL, Zhou J, Sun L, Zhao M, Kong SS, Wang YH, Yu XJ, Zhou J, Zang WJ (2011) Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Apoptosis 16:94\u2013103","journal-title":"Apoptosis"},{"key":"740_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215\u2013228","journal-title":"Cell"},{"key":"740_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","volume":"35","author":"H Nakagami","year":"2003","unstructured":"Nakagami H, Takemoto M, Liao JK (2003) NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 35:851\u2013859","journal-title":"J Mol Cell Cardiol"},{"key":"740_CR22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.01070.x","volume":"162","author":"Z Pan","year":"2011","unstructured":"Pan Z, Zhao W, Zhang X, Wang B, Wang J, Sun X, Liu X, Feng S, Yang B, Lu Y (2011) Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGF-\u03b21 expression and activation of p38-MAPK and ERK1\/2. Br J Pharmacol 162:688\u2013700","journal-title":"Br J Pharmacol"},{"key":"740_CR23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000256831.33459.ea","volume":"49","author":"JK Park","year":"2007","unstructured":"Park JK, Fischer R, Dechend R, Shagdarsuren E, Gapeljuk A, Wellner M, Meiners S, Gratze P, Al-Saadi N, Feldt S, Fiebeler A, Madwed JB, Schirdewan A, Haller H, Luft FC, Muller DN (2007) p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 49:481\u2013489","journal-title":"Hypertension"},{"key":"740_CR24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2005.08.010","volume":"40","author":"F Qin","year":"2006","unstructured":"Qin F, Patel R, Yan C, Liu W (2006) NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin. Free Radic Biol Med 40:236\u2013246","journal-title":"Free Radic Biol Med"},{"key":"740_CR25","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1096\/fasebj.6.6.1531968","volume":"6","author":"H Rupp","year":"1992","unstructured":"Rupp H, Elimban V, Dhalla NS (1992) Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J 6:2349\u20132353","journal-title":"FASEB J"},{"key":"740_CR26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","volume":"75","author":"J Sadoshima","year":"1993","unstructured":"Sadoshima J, Xu Y, Slayter HS, Izumo S (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977\u2013984","journal-title":"Cell"},{"key":"740_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000070250","volume":"13","author":"H Shi","year":"2003","unstructured":"Shi H, Yang B, Xu D, Wang H, Wang Z (2003) Electrophysiological characterization of cardiac muscarinic acetylcholine receptors: different subtypes mediate different potassium currents. Cell Physiol Biochem 13:59\u201374","journal-title":"Cell Physiol Biochem"},{"key":"740_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000076924","volume":"14","author":"H Shi","year":"2004","unstructured":"Shi H, Wang H, Li D, Nattel S, Wang Z (2004) Differential alterations of receptor densities of three muscarinic acetylcholine receptor subtypes and current densities of the corresponding K+ channels in canine atria with atrial fibrillation induced by experimental congestive heart failure. Cell Physiol Biochem 14:31\u201340","journal-title":"Cell Physiol Biochem"},{"key":"740_CR29","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.1016\/S0021-9258(17)30538-0","volume":"265","author":"HE Shubeita","year":"1990","unstructured":"Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH, Chien KR (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265:20555\u201320562","journal-title":"J Biol Chem"},{"key":"740_CR30","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","volume":"57","author":"VP Singh","year":"2008","unstructured":"Singh VP, Le B, Khode R, Baker KM, Kumar R (2008) Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57:3297\u20133306","journal-title":"Diabetes"},{"key":"740_CR31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","volume":"141","author":"BA Vakili","year":"2001","unstructured":"Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141:334\u2013341","journal-title":"Am Heart J"},{"key":"740_CR32","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/sj.bjp.0702486","volume":"126","author":"H Wang","year":"1999","unstructured":"Wang H, Shi H, Lu Y, Yang B, Wang Z (1999) Pilocarpine modulates the cellular electrical properties of mammalian hearts by activating a cardiac M3 receptor and a K+ current. Br J Pharmacol 126:1725\u20131734","journal-title":"Br J Pharmacol"},{"key":"740_CR33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","volume":"322","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins BJ, Molkentin JD (2004) Calcium\u2013calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322:1178\u20131191","journal-title":"Biochem Biophys Res Commun"},{"key":"740_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000089842","volume":"16","author":"B Yang","year":"2005","unstructured":"Yang B, Lin H, Xu C, Liu Y, Wang H, Han H, Wang Z (2005) Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac M3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 16:163\u2013174","journal-title":"Cell Physiol Biochem"},{"key":"740_CR35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","volume":"67","author":"SH Zeisel","year":"2009","unstructured":"Zeisel SH, da Costa KA (2009) Choline: an essential nutrient for public health. Nutr Rev 67:615\u2013623","journal-title":"Nutr Rev"},{"key":"740_CR36","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI25330","volume":"115","author":"P Zhai","year":"2005","unstructured":"Zhai P, Yamamoto M, Galeotti J, Liu J, Masurekar M, Thaisz J, Irie K, Holle E, Yu X, Kupershmidt S, Roden DM, Wagner T, Yatani A, Vatner DE, Vatner SF, Sadoshima J (2005) Cardiac-specific overexpression of AT1 receptor mutant lacking Gq\/Gi coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest 115:3045\u20133056","journal-title":"J Clin Invest"},{"key":"740_CR37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","volume":"63","author":"T Zhang","year":"2004","unstructured":"Zhang T, Brown JH (2004) Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63:476\u2013486","journal-title":"Cardiovasc Res"},{"key":"740_CR38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1476-5381.2009.00606.x","volume":"159","author":"J Zhao","year":"2010","unstructured":"Zhao J, Su Y, Zhang Y, Pan Z, Yang L, Chen X, Liu Y, Lu Y, Du Z, Yang B (2010) Activation of cardiac muscarinic M3 receptors induces delayed cardioprotection by preserving phosphorylated connexin43 and upregulating cyclooxygenase-2 expression. Br J Pharmacol 159:1217\u20131225","journal-title":"Br J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-012-0740-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0740-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T03:40:20Z","timestamp":1642218020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-012-0740-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1007\/s00210-012-0740-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}